Wednesday 22 September 2010

Conferensum.com announces that the documentation & proceedings from Ecole de paris conference is now available on its site.

Paris, France, 22 September 2010 - As the leading distributor of conference documentation (presentations, proceedings, audio and video), Conferensum.com is pleased to announce the arrival of new content from Ecole de paris.

The following documentation and proceedings from Ecole de paris are now available on our site:
Is the image of financial predators squeezing company assets, as private equity companies are portrayed, justified ? Do LBOs deserve the fiendish reputation that they have as a result of the secrecy surrounding their operations ?

During this seminar speakers gave their most current point of view on the opportunities and challenges of technology transfer with China.
The use and prospects of polymers and the identification of organic-based molecules to be used in the nutrition/health industry and in the plant-based or 'green' chemical industry

The use and prospects of polymers and the identification of organic-based molecules to be used in the nutrition/health industry and in the plant-based or 'green' chemical industry

The seminar topic was Thales' innovative business incubator known as the Emerging Business Initiative (or EBI). It has a very fast turn-around time of 48 hours during which projects are reviewed, approved and can get started.

For further information and access the documentation please visit Conferensum: Buy conference documentation

About Conferensum
Conferensum distributes and markets the content (documents, proceedings, presentations, audio and video) of past conferences via its multilingual online platform Conferensum.com and provides also a list of upcoming conferences and tradeshows. Conferensum, based in Paris, France, allows professionals and learning organizations, to be up to date on the latest trends and research in their sector.

Contact
7, rue Ambroise Thomas 75009 Paris
Tel: +33 9 51 20 18 25 | Fax: +33 1 70 24 75 65
Email: contact@conferensum.com

No comments: